SA firms win big in HIV drug contract

Comment on this story
iol pic aids drugs busrep AFP An Indian HIV-infected women poses with her antiretroviral drugs at her home in New Delhi.

Johannesburg - South African drugmakers are the big winners in a $667 million contract to supply HIV drugs awarded this week by the government of Africa's largest economy, with three local companies taking nearly 60 percent of the deal.

South Africa on Thursday awarded the two-year contract to 12 domestic and international firms to supply life-prolonging drugs to treat its biggest single health problem.

Aspen Pharmacare, Africa's largest generic drugs maker, has won 20.6 percent of the contract, while smaller rival Adcock Ingram was awarded 14 percent, the health department said in a statement.

Cipla Medpro, the drugmaker in which India's Cipla has offered to buy a majority stake, was awarded 9 percent, the government said.

A Cipla Medpro spokesman said its share of the contract rises to 24.5 percent when including wholly owned unit Medpro Pharmaceutica.

Medpro Pharmaceutica, which won 15.5 percent of the contract, tendered a separate bid from that of its parent.

Medpro Pharmaceutica will import the drugs from India, while Cipla Medpro is a local manufacturer, the spokesman said.

Cipla Medpro has a longstanding supply deal with India's Cipla.

That deal was spearheaded by former Cipla Medpro Chief Executive Jerome Smith, who quit last month following charges of gross misconduct for approving pay rises and bonuses for himself without board approval. - Reuters

sign up

Comment Guidelines

  1. Please read our comment guidelines.
  2. Login and register, if you haven’ t already.
  3. Write your comment in the block below and click (Post As)
  4. Has a comment offended you? Hover your mouse over the comment and wait until a small triangle appears on the right-hand side. Click triangle () and select "Flag as inappropriate". Our moderators will take action if need be.

  5. Verified email addresses: All users on Independent Media news sites are now required to have a verified email address before being allowed to comment on articles. You are only required to verify your email address once to have full access to commenting on articles. For more information please read our comment guidelines